» Articles » PMID: 18803879

Restoration of Tumor Suppressor MiR-34 Inhibits Human P53-mutant Gastric Cancer Tumorspheres

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2008 Sep 23
PMID 18803879
Citations 187
Authors
Affiliations
Soon will be listed here.
Abstract

Background: MicroRNAs (miRNAs), some of which function as oncogenes or tumor suppressor genes, are involved in carcinogenesis via regulating cell proliferation and/or cell death. MicroRNA miR-34 was recently found to be a direct target of p53, functioning downstream of the p53 pathway as a tumor suppressor. miR-34 targets Notch, HMGA2, and Bcl-2, genes involved in the self-renewal and survival of cancer stem cells. The role of miR-34 in gastric cancer has not been reported previously. In this study, we examined the effects of miR-34 restoration on p53-mutant human gastric cancer cells and potential target gene expression.

Methods: Human gastric cancer cells were transfected with miR-34 mimics or infected with the lentiviral miR-34-MIF expression system, and validated by miR-34 reporter assay using Bcl-2 3'UTR reporter. Potential target gene expression was assessed by Western blot for proteins, and by quantitative real-time RT-PCR for mRNAs. The effects of miR-34 restoration were assessed by cell growth assay, cell cycle analysis, caspase-3 activation, and cytotoxicity assay, as well as by tumorsphere formation and growth.

Results: Human gastric cancer Kato III cells with miR-34 restoration reduced the expression of target genes Bcl-2, Notch, and HMGA2. Bcl-2 3'UTR reporter assay showed that the transfected miR-34s were functional and confirmed that Bcl-2 is a direct target of miR-34. Restoration of miR-34 chemosensitized Kato III cells with a high level of Bcl-2, but not MKN-45 cells with a low level of Bcl-2. miR-34 impaired cell growth, accumulated the cells in G1 phase, increased caspase-3 activation, and, more significantly, inhibited tumorsphere formation and growth.

Conclusion: Our results demonstrate that in p53-deficient human gastric cancer cells, restoration of functional miR-34 inhibits cell growth and induces chemosensitization and apoptosis, indicating that miR-34 may restore p53 function. Restoration of miR-34 inhibits tumorsphere formation and growth, which is reported to be correlated to the self-renewal of cancer stem cells. The mechanism of miR-34-mediated suppression of self-renewal appears to be related to the direct modulation of downstream targets Bcl-2, Notch, and HMGA2, indicating that miR-34 may be involved in gastric cancer stem cell self-renewal/differentiation decision-making. Our study suggests that restoration of the tumor suppressor miR-34 may provide a novel molecular therapy for p53-mutant gastric cancer.

Citing Articles

Deregulation mechanisms and therapeutic opportunities of p53-responsive microRNAs in diffuse large B-cell lymphoma.

Voropaeva E, Orlov Y, Loginova A, Seregina O, Maksimov V, Pospelova T PeerJ. 2025; 13():e18661.

PMID: 39802185 PMC: 11720970. DOI: 10.7717/peerj.18661.


The Role of MicroRNA-124-3p in Breast Cancer Stem Cell Inhibition by Benzyl Isothiocyanate.

Kim S, Singh S Pharm Res. 2024; 41(10):1921-1932.

PMID: 39375243 PMC: 11792746. DOI: 10.1007/s11095-024-03775-2.


Combination of microRNA and suicide gene for targeting Glioblastoma: Inducing apoptosis and significantly suppressing tumor growth in vivo.

Fekrirad Z, Gharedaghi M, Saadatpour F, Molabashi Z, Rezayof A, Korourian A Heliyon. 2024; 10(17):e37041.

PMID: 39286083 PMC: 11403485. DOI: 10.1016/j.heliyon.2024.e37041.


The role of microRNAs in the gastric cancer tumor microenvironment.

Yu X, Zhang Y, Luo F, Zhou Q, Zhu L Mol Cancer. 2024; 23(1):170.

PMID: 39164671 PMC: 11334576. DOI: 10.1186/s12943-024-02084-x.


Multifunctional elastin-like polypeptide nanocarriers for efficient miRNA delivery in cancer therapy.

Hong J, Sim D, Lee B, Sarangthem V, Park R J Nanobiotechnology. 2024; 22(1):293.

PMID: 38802812 PMC: 11131307. DOI: 10.1186/s12951-024-02559-5.


References
1.
Meng Y, Tang W, Dai Y, Wu X, Liu M, Ji Q . Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa. Mol Cancer Ther. 2008; 7(7):2192-202. PMC: 2515935. DOI: 10.1158/1535-7163.MCT-08-0333. View

2.
Xu L, Tang W, Huang C, Alexander W, Xiang L, Pirollo K . Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv. Mol Med. 2001; 7(10):723-34. PMC: 1949994. View

3.
Welch C, Chen Y, Stallings R . MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene. 2007; 26(34):5017-22. DOI: 10.1038/sj.onc.1210293. View

4.
Corsten M, Miranda R, Kasmieh R, Krichevsky A, Weissleder R, Shah K . MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res. 2007; 67(19):8994-9000. DOI: 10.1158/0008-5472.CAN-07-1045. View

5.
Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N . Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell. 2007; 26(5):731-43. DOI: 10.1016/j.molcel.2007.05.017. View